Can ongoing neuronal injury release neural antigens and broaden autoreactive immune responses?

Neuronal injury is increasingly recognized as an immunologically active event: disruption of cells and CNS barriers can expose brain constituents that ordinarily have limited immune access. The antigen-release portion of the claim is well supported; subsequent epitope spreading and clinically consequential immune broadening remain biologically credible but unproven in humans.

Clinical and immune evidence

• After traumatic brain injury (TBI), intracellular neural proteins—including glial fibrillary acidic protein (GFAP), S100B, myelin basic protein (MBP), and neuronal proteins—are released into extracellular fluid and can reach the circulation when barrier integrity is impaired.
• In stroke, brain-derived MBP, microtubule-associated protein-2 (MAP2), and NR2A have been detected outside the injured CNS. Brain antigens have also been found in cervical lymph nodes and tonsils, accompanied by antigen-specific T-cell reactivity.
• Adaptive humoral responses can evolve after injury: anti-GFAP antibodies have risen by approximately day 7 after TBI and remained detectable at 6 months. Anti-S100B antibodies have been reported after repeated concussion, and neural autoantibodies have also been described after stroke.

Mechanistic interpretation

• Persistent or recurrent tissue injury could repeatedly supply additional neural antigens to antigen-presenting cells, creating conditions for recruitment of lymphocyte responses directed at further self epitopes or antigens—the defining concept of epitope spreading.
• The observed T-cell and antibody responses establish neural antigen recognition, but do not show that newly acquired specificities emerged sequentially from an initial response. Nor do they establish that these responses are pathogenic rather than markers of injury and barrier disruption.

Human-study interpretation

• In one small prospective stroke study, acute MBP-peptide T-cell responses were transient rather than sustained through 90 days. Associations of MBP-directed Th1 responses with infection and poorer outcomes are not evidence that immune broadening caused subsequent injury.

Bottom line

• Ongoing neuronal injury clearly exposes normally sequestered neural antigens and can induce neural antigen-specific T-cell and antibody responses. Epitope spreading and expansion of the autoreactive repertoire are plausible downstream mechanisms, but human longitudinal epitope-level evidence has not yet demonstrated them.